Work Here?
PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, and the company generates revenue through the sale of the AquaBeam system and its disposable components, as well as offering training and support services. PROCEPT BioRobotics stands out from competitors by providing a solution that ensures predictable outcomes and minimizes complications, ultimately enhancing patient quality of life. The goal of the company is to improve surgical procedures and patient outcomes in the treatment of BPH.
Company Stage
IPO
Employees
501-1,000
Industries
Biotechnology, Healthcare
Total Funding
$637.7M
Headquarters
N/A
Founded
2009
Help us improve and share your feedback! Did you find this helpful?
Find jobs on Simplify and start your career today